secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001104659-22-058283
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics Q1 revenue $2.5M; FDA approves Eversense E3 6-month CGM
------------------------------------------------------------------

- Q1 2022 total revenue $2.5M vs $2.8M YoY; U.S. revenue $0.8M up from $0.3M.
- Net income $86.7M ($0.19 EPS) vs net loss $249.5M (-$0.68 EPS) due to derivatives fair value adjustments.
- FDA approved Eversense E3 CGM with 6-month sensor wear; U.S. commercial launch underway with Ascensia.
- FY 2022 global revenue guidance reiterated at $14M-$18M.
- Cash & investments $166.9M, debt $104.7M as of March 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465922058283/0001104659-22-058283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465922058283/tm2215050d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-058283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer